These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 3666583)

  • 21. Validation of the Sysmex CS5100 coagulation analyzer and comparison to the Stago STA-R analyzer for routine coagulation parameters.
    Geens T; Vertessen F; Malfait R; Deiteren K; Maes MB
    Int J Lab Hematol; 2015 Jun; 37(3):372-81. PubMed ID: 25233923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of a new instrument (Coag-A-Mate X2) for performing global clotting tests and specific factor assays.
    Cugno MM; Chantarangkul V; Tripodi A; Mannucci PM
    Clin Lab Haematol; 1985; 7(1):75-81. PubMed ID: 4006406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analytical Assessment of the New Roche Cobas t 711 Fully Automated Coagulation Analyzer.
    Lippi G; Salvagno GL; Gelati M; Poli G; Giavarina D; Favaloro EJ
    Semin Thromb Hemost; 2019 Apr; 45(3):308-314. PubMed ID: 30699441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a bench-top coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and fibrinogen concentrations in healthy dogs.
    Mineo HK; Garabed RB
    Am J Vet Res; 2007 Dec; 68(12):1342-7. PubMed ID: 18052739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of thromboelastometry (ROTEM®) with standard plasmatic coagulation testing in paediatric surgery.
    Haas T; Spielmann N; Mauch J; Madjdpour C; Speer O; Schmugge M; Weiss M
    Br J Anaesth; 2012 Jan; 108(1):36-41. PubMed ID: 22086509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate.
    Douxfils J; Mullier F; Robert S; Chatelain C; Chatelain B; Dogné JM
    Thromb Haemost; 2012 May; 107(5):985-97. PubMed ID: 22438031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of chromogenic vs clot.based one stage APTT assay for determination of factor VIII level.
    Baig MA; Swamy KB
    Indian J Pathol Microbiol; 2021; 64(1):123-127. PubMed ID: 33433421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Problems with assays based on fibrin clot formation principle: analysis of multilaboratory data.
    Hirai N; Tatsumi N; Hino M; Yamane T; Ohta K
    Osaka City Med J; 1998 Jun; 44(1):55-71. PubMed ID: 9834619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the automated coagulation analyzer Sysmex(®) CS-2100i (Siemens)].
    Martin-Toutain I; Jobic L; Mancic T; Ankri A
    Ann Biol Clin (Paris); 2011; 69(6):699-704. PubMed ID: 22123571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of apixaban on commonly used coagulation assays: results from the Belgian national External Quality Assessment Scheme.
    Van Blerk M; Bailleul E; Chatelain B; Demulder A; Devreese K; Douxfils J; Jacquemin M; Jochmans K; Mullier F; Wijns W; China B; Vernelen K; Soumali MR
    Int J Lab Hematol; 2017 Aug; 39(4):402-408. PubMed ID: 28304137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance evaluation of the Sysmex CN-6000-automated coagulation analyzers for routine coagulation tests.
    Kim H; Jo SY; Kim IS
    Blood Coagul Fibrinolysis; 2023 Mar; 34(2):93-98. PubMed ID: 36719806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant factor IX: discrepancies between one-stage clotting and chromogenic assays.
    Wilmot HV; Hogwood J; Gray E
    Haemophilia; 2014 Nov; 20(6):891-7. PubMed ID: 24800651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteins invoked by vitamin K absence and clotting times in clinically ill cats.
    Center SA; Warner K; Corbett J; Randolph JF; Erb HN
    J Vet Intern Med; 2000; 14(3):292-7. PubMed ID: 10830543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to report results of prothrombin and activated partial thromboplastin times.
    Tripodi A; Lippi G; Plebani M
    Clin Chem Lab Med; 2016 Feb; 54(2):215-22. PubMed ID: 26351955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coagulation abnormalities in patients with chronic liver disease in Pakistan.
    Siddiqui SA; Ahmed M; Ghani MH; Memon MA; Mustafa G; Ghori MA
    J Pak Med Assoc; 2011 Apr; 61(4):363-7. PubMed ID: 21465974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Monitoring of Oral Thrombin Inhibitor].
    Matsuno K; Usami T; Hatuse M; Shimizu C
    Rinsho Byori; 2014 Oct; 62(10):958-64. PubMed ID: 27526541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability of prothrombin time and activated partial thromboplastin time in the diagnosis of increased surgical bleeding.
    Murray D; Pennell B; Olson J
    Transfusion; 1999 Jan; 39(1):56-62. PubMed ID: 9920167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter evaluation of a chromogenic substrate method for photometric determination of prothrombin time.
    Dati F; Barthels M; Conard J; Flückiger J; Girolami A; Hänseler E; Huber J; Keller F; Kolde HJ; Müller-Berghaus G
    Thromb Haemost; 1987 Oct; 58(3):856-65. PubMed ID: 3433249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of coagulation assays on Roche Cobas t711 analyzer: performance and clinical implications.
    Ordóñez-Robles M; Pons-Belda OD; Moína MJ; Bernardo-Gutiérrez Á; Prieto-García B
    Blood Coagul Fibrinolysis; 2023 Dec; 34(8):523-529. PubMed ID: 37823437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.